Ambar Protein [AMBARPIL] vs Gujarat Ambuja [GAEL] Detailed Stock Comparison
Ambar Protein
BSE
Loading...
Gujarat Ambuja
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Ambar Protein wins in 6 metrics, Gujarat Ambuja wins in 6 metrics, with 0 ties. Both stocks appear equally matched on key metrics.
View Metrics Details
Vital Metrics Comparison
| Metric | Ambar Protein | Gujarat Ambuja | Better |
|---|---|---|---|
| P/E Ratio (TTM) | N/A | 20.04 | N/A |
| Price-to-Book Ratio | 4.02 | 1.58 | Gujarat Ambuja |
| Debt-to-Equity Ratio | 74.75 | 7.62 | Gujarat Ambuja |
| PEG Ratio | N/A | -1.34 | N/A |
| EV/EBITDA | 10.64 | 10.81 | Ambar Protein |
| Profit Margin (TTM) | 1.95% | 4.94% | Gujarat Ambuja |
| Operating Margin (TTM) | 1.71% | 4.71% | Gujarat Ambuja |
| EBITDA Margin (TTM) | 1.71% | 4.71% | Gujarat Ambuja |
| Return on Equity | N/A | 8.30% | N/A |
| Return on Assets (TTM) | N/A | 6.95% | N/A |
| Free Cash Flow (TTM) | N/A | $441.50M | N/A |
| Dividend Yield | N/A | 0.31% | N/A |
| 1-Year Return | 66.81% | -24.25% | Ambar Protein |
| Price-to-Sales Ratio (TTM) | 0.31 | 0.99 | Ambar Protein |
| Enterprise Value | $1.68B | $42.05B | Gujarat Ambuja |
| EV/Revenue Ratio | 0.38 | 0.87 | Ambar Protein |
| Gross Profit Margin (TTM) | N/A | 24.64% | N/A |
| Revenue per Share (TTM) | $776 | $105 | Ambar Protein |
| Earnings per Share (Diluted) | N/A | $5.19 | N/A |
| Beta (Stock Volatility) | -2.16 | -0.22 | Ambar Protein |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Ambar Protein vs Gujarat Ambuja Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Ambar Protein | -1.99% | -6.87% | -32.52% | 12.44% | 24.14% | 25.12% |
| Gujarat Ambuja | -1.45% | -0.14% | -5.99% | -10.79% | -3.84% | -17.43% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Ambar Protein | 66.81% | -15.61% | 1,508.77% | 1,508.77% | 1,508.77% | 1,508.77% |
| Gujarat Ambuja | -24.25% | -29.87% | 117.84% | 786.47% | 703.88% | 1,495.38% |
Performance & Financial Health Analysis: Ambar Protein vs Gujarat Ambuja
| Metric | AMBARPIL | GAEL |
|---|---|---|
| Market Information | ||
| Market Cap | ₹1.40B | ₹47.70B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 347 | 331,571 |
| 90 Day Avg. Volume | 554 | 402,514 |
| Last Close | ₹244.05 | ₹103.54 |
| 52 Week Range | ₹144.40 - ₹432.85 | ₹98.72 - ₹151.91 |
| % from 52W High | -43.62% | -31.84% |
| All-Time High | ₹843.50 (Sep 26, 2022) | ₹210.60 (Jan 29, 2024) |
| % from All-Time High | -71.07% | -50.84% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.26% | 0.18% |
| Quarterly Earnings Growth | -0.57% | -0.15% |
| Financial Health | ||
| Profit Margin (TTM) | 0.02% | 0.05% |
| Operating Margin (TTM) | 0.02% | 0.05% |
| Return on Equity (TTM) | N/A | 0.08% |
| Debt to Equity (MRQ) | 74.75 | 7.62 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹60.65 | ₹65.88 |
| Cash per Share (MRQ) | ₹2.10 | ₹16.85 |
| Operating Cash Flow (TTM) | ₹0 | ₹3.14B |
| Levered Free Cash Flow (TTM) | ₹0 | ₹2.49B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.31% |
| Last 12-Month Dividend | N/A | ₹0.35 |
Valuation & Enterprise Metrics Analysis: Ambar Protein vs Gujarat Ambuja
| Metric | AMBARPIL | GAEL |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | N/A | 20.04 |
| Forward P/E | N/A | 11.18 |
| PEG Ratio | N/A | -1.34 |
| Price to Sales (TTM) | 0.31 | 0.99 |
| Price to Book (MRQ) | 4.02 | 1.58 |
| Market Capitalization | ||
| Market Capitalization | ₹1.40B | ₹47.70B |
| Enterprise Value | ₹1.68B | ₹42.05B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.38 | 0.87 |
| Enterprise to EBITDA | 10.64 | 10.81 |
| Risk & Other Metrics | ||
| Beta | -2.16 | -0.22 |
| Book Value per Share (MRQ) | ₹60.65 | ₹65.88 |
Financial Statements Comparison: Ambar Protein vs Gujarat Ambuja
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | AMBARPIL | GAEL |
|---|---|---|
| Revenue/Sales | N/A | ₹12.67B |
| Cost of Goods Sold | N/A | ₹9.86B |
| Gross Profit | N/A | ₹2.80B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | ₹304.70M |
| EBITDA | N/A | ₹872.00M |
| Pre-Tax Income | N/A | ₹491.80M |
| Income Tax | N/A | ₹173.10M |
| Net Income (Profit) | N/A | ₹318.70M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | AMBARPIL | GAEL |
|---|---|---|
| Cash & Equivalents | N/A | ₹12.20M |
| Total Current Assets | N/A | ₹19.38B |
| Total Current Liabilities | N/A | ₹4.58B |
| Long-Term Debt | N/A | ₹98.20M |
| Total Shareholders Equity | N/A | ₹30.02B |
| Retained Earnings | N/A | N/A |
| Property, Plant & Equipment | N/A | ₹11.78B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | AMBARPIL | GAEL |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | AMBARPIL | GAEL |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 347 | 331,571 |
| Average Daily Volume (90 Day) | 554 | 402,514 |
| Shares Outstanding | 5.75M | 458.67M |
| Float Shares | 953,370 | 137.05M |
| % Held by Insiders | 0.79% | 0.70% |
| % Held by Institutions | 0.00% | 0.01% |
Dividend Analysis & Yield Comparison: Ambar Protein vs Gujarat Ambuja
| Metric | AMBARPIL | GAEL |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹0.35 |
| Last 12-Month Dividend Yield | N/A | 0.31% |
| 3-Year Avg Annual Dividend | N/A | ₹0.23 |
| 3-Year Avg Dividend Yield | N/A | 0.16% |
| 3-Year Total Dividends | N/A | ₹0.68 |
| Ex-Dividend Date | N/A | Aug 23, 2024 |